This study, called GYN-AIDE, is looking at how women with endometrial carcinoma (a type of uterine cancer) find health information and how satisfied they are with it. It also explores their interest in using an artificial intelligence (AI) educational tool. Specifically, the study will evaluate an AI chatbot designed to provide information about the HPV vaccine. Researchers want to see how satisfied patients are with this chatbot and if using it can increase HPV vaccination rates. You may be able to join if you are an adult woman (18 or older) receiving care at the LA General gynecologic oncology clinic, speak English or Spanish, and are willing to provide informed consent. The study is currently unclear on its recruitment status and plans to enroll 48 participants.

Study design

This is an observational study, meaning researchers will observe and collect information without providing a specific treatment. It plans to include 48 women.

What's involved

You would complete a survey as part of this study.

Compensation

Not stated in the trial record.

Follow-up

Patient satisfaction and HPV vaccination rates will be measured for up to 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.